Adageis is Ramping Up Patient Care for All Healthcare Providers and Systems via a Powerful Patented AI-Centric Software

• Adageis, with its virtual quality care manager and productivity suite, aims to improve healthcare delivery by helping providers streamline operations and increase revenue through value-based care metrics by implementing its patented ProActive Care Platform.
• Easily scalable and adaptable, the platform is designed to fit with the electronic medical record systems of any healthcare provider, regardless of size, locations or number of patients.
• A unique offering in the healthcare technology space, the ProActive Care Platform offers flexible integration, proactive efficiency and advanced predictive analysis capabilities.
• Adageis is targeting a share of the fast-growing healthcare AI market, which was valued at 19.27 billion in 2023.

Adageis, a forward-thinking healthcare technology company, is reshaping patient care through flexible AI-centric software solutions for healthcare systems and providers, including accountable care organizations (“ACOs”), clinically integrated networks (“CINs”) and independent physician associations (“IPAs”). With a unique value proposition in the healthcare technology space, the company is actively improving healthcare delivery and increasing value-based care revenue by streamlining operations via its ProActive Care Platform.

Integrating AI and machine learning, this easy-to-use platform works with existing electronic health records (“EHR”) systems and fits the needs of all current healthcare platforms, whether operated by providers owning a single clinic or a multispecialty healthcare system. Through a dedicated application program interface, the company can pair its platform with providers’ existing EHR systems. Their AI approach to advanced analytics and risk analysis empowers users to better identify high risk patients and quality care gaps, all while influencing everything from supply chain, to physical business location, to care delivery.

Importantly, this platform’s design eliminates the need for costly infrastructure upgrades or extensive staff training, reducing adoption barriers and enabling organizations to increase revenue and thrive in today’s complex value-based care environment. The platform is easily scalable, with various packages available to meet a wide range of user needs. The ProActive Care Platform also supports patient-centered care while optimizing reimbursements linked to quality metrics and value-based contracts.

Key features include:

• Value-Based Care Engine: One platform to enable an organization’s value-based care transformation, driving revenue from meeting value-based care metrics while providing high-quality patient care.
• Patented Risk Engine (“PRE”): AI-driven insights identify high-risk patients and care gaps, enabling providers to improve outcomes and manage costs effectively.
• Proactive Efficiency: Monitors patient health continuously, allowing for timely interventions beyond traditional office visits, improving care efficiency and reducing expenses.
• Flexible Integration: Compatible with leading EMR systems such as AthenaHealth, Cerner, eClinicalWorks, Allscripts, and Epic, ensuring smooth implementation without disrupting workflows or requiring extensive training.

The company’s efforts to revolutionize healthcare delivery via innovative software solutions are spearheaded by a leadership team with extensive experience in healthcare and technology. CEO Shane Speirs, MD, MBA, is a board-certified physician in family and geriatric medicine with extensive experience in healthcare leadership, data modeling and AI applications in healthcare delivery. CTO Bill Jentarra, MBA, has over 25 years of experience in architecting and implementing complex client relationship management and business intelligence solutions across various industries, including healthcare.

Headquartered in Arizona, Adageis is already driving meaningful change in the industry, as the global healthcare AI market is expanding rapidly amid growing demand for improved patient outcomes (https://ibn.fm/wDsy1). Strategic partnerships, including collaborations with HealthyU Clinics and integration as an AthenaHealth marketplace partner, further highlight the company’s relevance and adaptability in the evolving healthcare landscape, and its unique position to capitalize on these trends and capture a significant stake in the $19.27 billion healthcare AI market.

For more information, visit the company’s website at www.Adageis.com.

NOTE TO INVESTORS: The latest news and updates relating to Adageis are available in the company’s newsroom at https://ibn.fm/Adageis

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN